Plasma Homocysteine Predicts Mortality Independently of Traditional Risk Factors and C-Reactive Protein in Patients With Angiographically Defined Coronary Artery Disease
- 12 September 2000
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 102 (11), 1227-1232
- https://doi.org/10.1161/01.cir.102.11.1227
Abstract
Background—Plasma homocysteine (tHCY) has been associated with coronary artery disease (CAD). We tested whether tHCY also increases secondary risk, after initial CAD diagnosis, and whether it is in...Keywords
This publication has 25 references indexed in Scilit:
- Biochemistry and molecular genetics of cystathionine β-synthase deficiencyEuropean Journal of Pediatrics, 1998
- Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trialsBMJ, 1998
- Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1997
- Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy MenNew England Journal of Medicine, 1997
- A common mutation in methylenetetrahydrofolate reductase gene is not a major risk of coronary artery disease or myocardial infarctionAtherosclerosis, 1997
- A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians.Journal of the American College of Nutrition, 1996
- A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular DiseaseJAMA, 1995
- Serum Total Homocysteine and Coronary Heart DiseaseInternational Journal of Epidemiology, 1995
- Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly PopulationJAMA, 1993
- Solid phase radioimmunoassays for human C-reactive proteinClinica Chimica Acta; International Journal of Clinical Chemistry, 1981